MING BIOVENTURES
Ming Bioventures is a professional venture capital institution focusing on innovative medicines, medical devices & new diagnostics.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-02 | Mesai Biotech | Ming Bioventures investment in Series A - Mesai Biotech | N/A |
| 2022-08-23 | Redbud Medicine | Ming Bioventures investment in Series A - Redbud Medicine | 10 M USD |
| 2022-01-01 | Kossel Medical | Ming Bioventures investment in Venture Round - Kossel Medical | 100 M CNY |
| 2021-11-15 | Jisi Yingda | Ming Bioventures investment in Series B - Jisi Yingda | N/A |
| 2021-11-15 | Help Stem Cell Innovations | Ming Bioventures investment in Series C - Help Stem Cell Innovations | 25 M USD |
| 2021-09-16 | Ubrigene | Ming Bioventures investment in Series B - Ubrigene | 200 M CNY |
| 2021-04-08 | Abogen Biosciences | Ming Bioventures investment in Series B - Abogen Biosciences | 600 M CNY |
| 2021-03-22 | Tavotek Biotherapeutics | Ming Bioventures investment in Series A - Tavotek Biotherapeutics | 20 M USD |
| 2021-01-11 | NuProbe | Ming Bioventures investment in Series B - NuProbe | 42 M USD |
| 2020-06-15 | Jisi Yingda | Ming Bioventures investment in Series A - Jisi Yingda | 100 M CNY |
More informations about "Ming Bioventures"
Ming Bioventures - Crunchbase Investor Profile & Investments
Ming Bioventures is a professional venture capital institution focusing on innovative medicines, medical devices & new diagnostics. Ming Bioventures invests in seed to early-stage …See details»
Ming Bioventures investment portfolio | PitchBook
Founded in 2018, Ming Bioventures is a venture capital firm based in Suzhou, China. It seeks to make investments in life science sectors including Innovative drugs, medical devices, and …See details»
Ming Bioventures - Investments, Portfolio & Company Exits
Ming Bioventures is a professional venture capital institution focusing on innovative medicines, medical devices & new diagnostics.See details»
Keythera completed RMB 100M Series A financing
Recently, Keythera (Suzhou) Biopharmaceutical Co., Ltd., an innovative drug research and development enterprise, announced the completion of a Series A financing of nearly RMB 100 …See details»
Ming Bioventures | Investor | RadialReport
Ming Bioventures is a professional venture capital institution focusing on innovative medicines, medical devices & new diagnostics. Invests into Viva BiotechSee details»
Ming Bioventures Fund II: Performance - PitchBook
Sep 16, 2021 · Ming Bioventures Fund II has made numerous investments in companies like Keqin Micro Vision Medical Device, Yiming Cell, and Infinovo within the Surgical Devices, …See details»
MING Bioventures - VC Firm Profile - Gaebler.com Venture Capital …
VC investing group MING Bioventures provides capital to high-potential tech companies.See details»
Ming Bioventures - Contacts, Employees, Board Members
Ming Bioventures is a professional venture capital institution focusing on innovative medicines, medical devices & new diagnostics.See details»
Ming Bioventures - ExploreBit - ExploreBit
Ming Bioventures is a professional venture capital institution focusing on innovative medicines, medical devices & new diagnostics. Find everything about Ming Bioventures, it's employees, …See details»
Ming Bioventures - BioCentury Company Profiles - BCIQ
Dec 27, 2019 · Riverhead, Ping An lead Lepu’s megaround Lepu Biotechnology Co. Ltd. raised RMB1.3 billion ($185.3 million) in a series B round jointly led by Riverhead Capital and Ping …See details»
Ming Bioventures Leads ~USD14m Series B for China’s Minimax …
Dec 30, 2022 · Ming Bioventures led a ~CNY100m (~USD14m) Series B for Minimax Medical, a China-based developer of minimally invasive medical devices, with participation from Cowin …See details»
Ming Bioventures — 26 Investments, Performance ... - Unicorn Nest
Ming Bioventures appeared to be the VC, which was created in 2018. The main office of represented VC is situated in the Suzhou. The fund was located in Asia if to be more exact in …See details»
Redbud raises $10M in series A round as CRO focusing on science …
Sep 9, 2022 · Redbud Medicine, the Delaware-headquartered contract research organization (CRO) announced on Monday following the completion of a series A round fundraising in …See details»
Ming Bioventures - Updates, News, Events, Signals & Triggers
Ming Bioventures is a professional venture capital institution focusing on innovative medicines, medical devices & new diagnostics.See details»
Ming Bioventures Fund Manager Profile | Preqin
Established in April 2018, Ming Bioventures is a venture firm based in Suzhou, China. Its investments focus on healthcare, including pharmaceutical, medical devices and …See details»
Ming Bioventures Fund I: Performance - PitchBook
Dec 10, 2019 · Information on investments, limited partners, investment strategy, and returns for Ming Bioventures Fund I. Use the PitchBook Platform to explore the full profile.See details»
Help Therapeutics Completes Series C Financing of 25 Million Dollars
Nov 29, 2021 · This round of financing was led by Ming Bioventures, followed by Share Capital, Beisen Medical Fund, and Jolmo Capital, with additional support from our old shareholder …See details»
Redbud Raises $10M in Series A Funding - finsmes.com
Sep 12, 2022 · Redbud Medicine, a Delaware-headquartered contract research organization (CRO), raised $10M in Series A funding. The round was led by MING Bioventures Capital, …See details»
Ming Bioventures - Tech Stack, Apps, Patents & Trademarks
Ming Bioventures is a professional venture capital institution focusing on innovative medicines, medical devices & new diagnostics.See details»
WuXi Biologics to Acquire CMAB and Form Strategic Partnership …
Mar 18, 2021 · WuXi Biologics (stock code: 2269.HK), a Hong Kong -listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower …See details»